Copyright © Inderes 2011 - present. All rights reserved.

Oriola

0.938

 

EUR

 

+2.51 %

OKDBV

NASDAQ Helsinki

Medical Equipment & Services

Health Care

7,626 following
+2.51%
+0.21%
-0.85%
+0.54%
-13.79%
-7.86%
-53.45%
-55.12%
-49%
www.oriola.com/investors

Oriola is a pharmaceutical group with a special focus on the distribution of pharmaceuticals to other companies in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest presence is in the Nordic and Baltic countries. The head office is located in Espoo.

P/E (adj.) (24e)
25.05
EV/EBIT (adj.) (24e)
4.15
P/B (24e)
1.08
Dividend yield-% (24e)
8.53 %
Target price
1.00 EUR
Recommendation
Accumulate
Updated
31.10.2024
NASDAQ Helsinki
OKDBV
Daily low / high price
0.908 / 0.938 EUR
Market cap
170.23M EUR
Turnover
62.22K EUR
Volume
68K
Business risk
Valuation risk
Current
Previous

Analyst

Rauli Juva
Rauli Juva
Analyst

Latest videos

Oriola Q3’24: Building the foundation
2024-10-30
Oriola-KD Oyj, Q3'24
2024-10-30
Oriola Q2’24: Sales growth in both segments
2024-07-18

Financial calendar

Annual report
2025-03-04
General meeting
2025-04-02
Interim report
2025-04-29
Interim report
2025-07-18
Interim report
2025-10-30

Income statement

20202021202220232024e2025e2026e2027e
Revenue1,800.81,882.41,841.41,493.81,685.91,776.71,862.31,952.0
growth-%4.6 %4.5 %-2.2 %-18.9 %12.9 %5.4 %4.8 %4.8 %
EBITDA63.165.468.630.127.726.728.130.2
EBIT (adj.)21.026.334.516.721.824.025.527.0
EBIT20.420.540.2-5.314.116.017.519.0
Profit before taxes14.314.735.4-17.61.210.516.518.6
Net income11.311.327.4-20.7-0.58.213.815.4
EPS (adj.)0.070.090.120.010.040.080.110.12
growth-%-9.6 %44.4 %26.9 %-94.1 %434.6 %112.5 %38.5 %8.2 %
Dividend0.030.040.060.070.080.090.100.06
Dividend ratio48.2 %64.2 %39.7 %-61.2 %-3,085.9 %199.2 %131.9 %75.0 %

Profitability and return on capital

20202021202220232024e2025e2026e2027e
EBITDA-%3.5 %3.5 %3.7 %2.0 %1.6 %1.5 %1.5 %1.5 %
EBIT-% (adj.)1.2 %1.4 %1.9 %1.1 %1.3 %1.4 %1.4 %1.4 %
EBIT-%1.1 %1.1 %2.2 %-0.4 %0.8 %0.9 %0.9 %1.0 %
ROE6.9 %5.8 %12.4 %-10.4 %-0.3 %5.3 %9.1 %10.4 %
ROI5.0 %4.6 %10.2 %-3.1 %3.1 %6.7 %9.6 %10.6 %

Valuation

20202021202220232024e2025e2026e2027e
Share price (EUR)1.902.011.720.920.940.940.940.94
Shares181.3181.3181.3181.3181.3181.3181.3181.3
Market cap344.5364.5311.9166.8170.1170.1170.1170.1
Enterprise value471.6465.3288.2103.590.486.493.9104.8
EV/S0.30.20.20.10.10.00.10.1
EV/EBITDA7.57.14.23.43.33.23.33.5
EV/EBIT (adj.)22.517.78.46.24.13.63.73.9
EV/EBIT23.122.77.2-6.45.45.45.5
P/E (adj.)29.121.314.4131.325.011.88.57.9
P/E30.632.311.4--20.812.411.1
P/B2.01.71.41.01.11.11.11.2
P/S0.20.20.20.10.10.10.10.1
Dividend yield1.6 %2.0 %3.5 %7.6 %8.5 %9.6 %10.7 %6.8 %
Equity ratio14.5 %19.8 %23.5 %18.3 %16.9 %15.8 %15.5 %14.6 %
Gearing ratio74.9 %46.5 %-10.5 %-12.0 %-21.8 %-25.4 %-20.8 %-13.8 %

Quarter data

Q4/232023Q1/24Q2/24Q3/24Q4/24e2024eQ1/25eQ2/25e
Revenue386.51,493.8375.1439.5424.4446.91,685.9
EBITDA8.330.16.78.64.97.527.7
EBIT5.3-5.33.75.70.24.514.1
Profit before taxes-0.8-17.6-2.02.8-2.22.51.2
Net income-2.7-20.7-2.31.9-1.91.9-0.5
Login in to make your own estimates and see other investors estimates.
ShowingAll content types
Oriola Q3’24: Building the foundation
Video by
Rauli Juva

Oriola Q3’24: Building the foundation

Changes in Oriola’s management group continued, with the focus now on creating a sustainable foundation. Despite achieving strong revenue growth, Oriola unexpectedly recorded substantial one-time costs related to the ERP project.

Oriola

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Oriola Q2’24: Sales growth in both segments
Video by
Rauli Juva

Oriola Q2’24: Sales growth in both segments

Oriola’s Q2 earnings were quite in line with our estimates and the guidance for the whole year of 2024 remained unchanged. The joint venture company in Sweden performed better than we expected after two very weak quarters. CEO Katarina Gabrielson comments on the Q2 result in this interview.

Oriola